ArticleFrontiers in public health2024
Quantitative evaluation of the medicine innovation policy in China: based on the PMC-Index model.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Quantitative evaluation of the medical resource allocation policy in China: a PMC-index model approach.Cost effectiveness and resource allocation : C/E · 2026Article
- Comparison of national health planning policies in China and ASEAN: a PMC-index model analysis.Cost effectiveness and resource allocation : C/E · 2026Article
- Quantitative evaluation of China's smart aging healthcare policy under the background of silver economy development: based on PMC model.Frontiers in public health · 2026Article
- Quantitative assessment of china's policies on the online sale of prescription drugs.PloS one · 2026Article
- Empowering chronic disease management with smart healthcare in China: a policy effectiveness evaluation by PMC index model.Frontiers in public health · 2026Article
- Research on China's population health policy: an analysis based on the PMC index model.BMC public health · 2025Article
- Quantitative evaluation of China's new health insurance payment policy based on the policy modeling consistency (PMC) index model.BMC health services research · 2025Article
- Quantitative evaluation of policy texts of hospital workplace violence prevention and control in China: based on the PMC-Index model.BMC public health · 2025Article
- Quantitative evaluation of two-way referral policies based on PMC index model.International journal for equity in health · 2025Article
- Quantitative evaluation of China's adolescent physical activity policies: a PMC Index model approach.Frontiers in public health · 2025Article
- Quantitative analysis of the diffusion characteristics of China's long-term care insurance policy based on the PMC index model.Frontiers in public health · 2025Article
- Comprehensive evaluation of the development of traditional Chinese medicine industry in Shaanxi province based on PMC index model.Frontiers in public health · 2025Article
- Evolution of traditional Chinese medicine registration review and approval policies: research based on the LDA topic model.Frontiers in public health · 2025Article
- Quantitative analysis of medical quality intelligent management policies in China: a PMC index model approach.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Medicine innovation is crucial in promoting the sustainable development of medicine undertakings, which has significant economic and social benefits. China is the main force in global medicine consumption, with a huge demand for innovative medicines. Thus, the Chinese government releases a series of policies aimed at providing scientific and reasonable guidance for medicine innovation. However, there is inadequate quantitative evaluation and comparison of various medicine innovation policies in the existing studies. Methods: This paper adopts the approach of text mining and the Policy Modeling Consistency Index (PMC-Index) model to construct an evaluation system and then quantitatively evaluates and compares the traditional Chinese medicine innovation policies (TCMIPs), the biological medicine innovation policies (BMIPs), and the multiple medicine innovation policies (MMIPs) in China. Results: The results indicate that: (1) The three types of drug innovation policies have similarities in content and goal through comparative analysis of high-frequency words, while they also have their own characteristics. (2) The average PMC-Index of 29 TCMIPs is 5.77, which has the highest policy bad rate (21%); the average PMC-Index of 12 BMIPs is 6.21, which has the highest policy good rate (92%); moreover, the average PMC-Index of 35 MMIPs is 6.06, which has the highest policy excellence rate (26%). (3) The BMIPs, MMIPs, and TCMIPs have similar scores on policy object, policy orientation, policy timeliness, policy evaluation, and policy accessibility, while they differ significantly mainly on policy nature, incentive method, policy function, policy issuing agency, and policy instrument. Discussion: This study contributes to a comprehensive understanding of medicine innovation policies in China, in order to provide theoretical support for future policy formulation and optimization in the medicine industry. Moreover, we expand the application scenarios of policy diffusion theory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.